Lifegene-Biomarks, Inc.
Publicly observedSan Juan, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | San Juan | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Lifegene-Biomarks, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | GGR9ABCTBGG5 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant1 Jun 2024Publicly observed
NIH SBIR/STTR award: Precision screening in self-collected samples to reduce cervical cancer disparities among Latinas
USD 366,433.00 · National Institute on Minority Health and Health Disparities · Source: NIH RePORTER (opens in a new tab)
- Grant1 Jun 2024Publicly observed
NIH SBIR/STTR award: Precision screening in self-collected samples to reduce cervical cancer disparities among Latinas
USD 1,456,725.00 · National Institute on Minority Health and Health Disparities · Source: NIH RePORTER (opens in a new tab)
- Grant20 Sept 2023Publicly observed
NIH SBIR/STTR award: Precision DNA methylation test to reduce oral cancer disparities in African Americans patients residing in low-resource settings
USD 900,350.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
- Grant20 Sept 2023Publicly observed
NIH SBIR/STTR award: Precision DNA methylation test to reduce oral cancer disparities in African Americans patients residing in low-resource settings
USD 912,858.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.